EBOS MedTech

What EBOS MedTech does

EBOS MedTech is a privately held portfolio of medical technology companies operating under ASX-listed parent EBOS Group, with headquarters in North Ryde (Sydney), Australia. It serves healthcare providers across Australia, New Zealand, the United States, Southeast Asia (Singapore, Malaysia, Vietnam, Thailand, Indonesia, Philippines), and Hong Kong through six core operating subsidiaries: LifeHealthcare (medical technology distribution across spine, orthopaedics, abdo-pelvic surgery, neurosurgery, robotics, plastics and reconstructive surgery, and neurovascular intervention in ANZ); Transmedic (medical technology and specialty pharmaceutical distribution in Southeast Asia and Hong Kong); Australian Biotechnologies (manufacture and distribution of allograft tissue products in Australia); Cryomed Aesthetics (aesthetic healthcare technologies across ANZ); Origin Biologics (US-market regenerative medicine allograft solutions via a partnership with Nevada Donor Network); and alphaXRT (radiation oncology solutions across ANZ, acquired in 2025).

The portfolio combines distribution of third-party and own-manufactured medical technologies with proprietary biomaterials. Notable internally developed products include the Allovance ADM (Acellular Dermal Matrix) — built on proprietary aseptic processing and supercritical fluid decellularisation after four years of R&D — and Origin Biologics' Dry State Technologies that preserve donor tissue viability without carriers. Radiation oncology capabilities are delivered through representation of Accuray, RaySearch, Sun Nuclear/Mirion, TAE Lifesciences, and MacroMedics. The DDU (Deformity Discussion Union) surgeon-education programs, now in their 15th edition in ANZ and a second-edition rollout into ASEAN, anchor clinician engagement.

The company monetises through hardware and consumable sales into healthcare providers on multi-year B2B contracts with quote-based pricing, executed principally via direct enterprise field sales teams in ANZ and channel/distributor models in Southeast Asia. A logistics partnership with Australia Post's RENDR platform (announced May 2026) supports multi-carrier delivery orchestration across Cryomed and LifeHealthcare warehouses. Revenue figures are not publicly disclosed, and the company has no external funding rounds; financial scaling occurs within EBOS Group's broader healthcare and animal-care portfolio.

Name

EBOS MedTech

Legal name

EBOS Medical Devices Australia Pty Limited

Website

https://ebosmedtech.com

Company type

Private

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

EBOS MedTech is a portfolio of medical technology companies under EBOS Group, operating across Australia, New Zealand, USA, Southeast Asia, and Hong Kong. It distributes advanced medical devices, manufactures allograft tissue products, and supplies radiation oncology and aesthetic technologies to healthcare providers.

Ownership category

akta.pro rank

Product category

Medical Technology Distribution and Biologics Manufacturing

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical technology distribution
• Surgical device distribution
• Allograft tissue manufacturing
• Radiation oncology solutions
• Aesthetic healthcare technologies

Headquarters

HQ city

North Ryde

HQ country

Australia

HQ region

Oceania

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medical Technology Distribution: Distribution of advanced medical technologies including spine, orthopaedics, abdo pelvic surgery, neurosurgery, robotics, plastics and reconstructive surgery, and neurovascular intervention across ANZ.
2. SE Asia Medical Device Distribution: Distribution of high-end medical devices, specialty pharmaceuticals, and diagnostic solutions across Southeast Asia and Hong Kong.
3. Allograft Tissue Products: Manufacturing and distribution of life-enhancing allograft tissue products for the Australian community through Australian Biotechnologies.
4. Aesthetic Healthcare Technologies: Distribution of aesthetic healthcare technologies including skin rejuvenation, body contouring, and energy-based treatments across ANZ.
5. Radiation Oncology Solutions: Supply of radiation oncology solutions including treatment delivery, planning, medical physics and QA, and patient positioning across ANZ.
6. US Allograft Solutions: Manufacturing and distribution of advanced allograft solutions in the US market through Origin Biologics partnership with Nevada Donor Network.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

EBOS MedTech is a connected portfolio of medical technology companies that distribute advanced medical devices (spine, orthopaedics, neurosurgery, robotics, plastics and reconstructive surgery, neurovascular intervention, and radiation oncology) and manufacture allograft tissue products for surgeons, hospitals, oncology centres, and aesthetic clinics across Australia, New Zealand, USA, Southeast Asia, and Hong Kong. The portfolio combines local manufacturing capability (Australian Biotechnologies, Origin Biologics) with specialist distribution (LifeHealthcare, Transmedic, Cryomed Aesthetics, alphaXRT) and surgeon-led education programs.

Product overview

EBOS MedTech is a connected portfolio platform of medical technology companies improving lives across Australia, New Zealand, USA, Southeast Asia, and Hong Kong. The platform consists of five core companies: LifeHealthcare (medical technologies spanning spine, orthopaedics, neurosurgery, robotics, plastics/reconstructive surgery, and neurovascular intervention), Transmedic (medical technology distribution across Southeast Asia and Hong Kong), Australian Biotechnologies (allograft tissue products for ANZ), Cryomed Aesthetics (aesthetic healthcare technologies), and Origin Biologics (allograft solutions for the US). Key products include Allovance ADM for regenerative surgery, alphaXRT for radiation oncology, and RENDR for delivery orchestration. The DDU education programs serve spine surgeons across ANZ and ASEAN regions. The companies are united by shared value of Connect, providing deep technical expertise, education, and surgical support to improve patient outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• LifeHealthcare Medical technology distribution business providing access to world-leading medical technologies for patients across Australia and New Zealand, spanning spine, orthopaedics, abdo pelvic surgery, neurosurgery, robotics, plastics and reconstructive surgery, and neurovascular intervention through field sales, technical expertise, and surgical support.
• Transmedic Leading independent medical technology distributor across Southeast Asia and Hong Kong delivering high-end medical devices, specialty pharmaceuticals, diagnostic solutions, blood therapy equipment, and consumables with technology, education, and hands-on clinical support.
• Australian Biotechnologies Australian manufacturer and distributor of life-enhancing allograft tissue products that restore movement, function, and quality of life through advanced manufacturing, ethical sourcing, and rigorous quality standards, including the Allovance ADM Acellular Dermal Matrix.
• Cryomed Aesthetics Leading provider of aesthetic healthcare technologies across Australia and New Zealand spanning skin rejuvenation, body contouring, and energy-based treatments, combining science, performance, and patient safety to empower practitioners to grow their practices.
• Origin Biologics U.S.-based regenerative medicine company delivering advanced allograft solutions to support the body's natural healing potential, providing differentiated bone grafting solutions without carriers using proprietary Dry State Technologies in partnership with Nevada Donor Network.
• Allovance ADM (Acellular Dermal Matrix) World-leading allograft solution utilizing dermal matrix for surgeons and patients across Australia and New Zealand, supporting soft tissue regeneration in breast reconstruction, shoulder reconstruction, tendon repair, and oral and maxillofacial (OMF) surgery.
• alphaXRT Radiation Oncology Solutions Leading independent supplier of radiation oncology solutions across Australia and New Zealand supporting treatment delivery, planning, medical physics and QA, and patient positioning. Represents partners including Accuray, RaySearch, Sun Nuclear/Mirion, TAE Lifesciences, and MacroMedics.

Quantifiable outcome

• alphaXRT acquisition strengthens oncology clinician support with precision technology and on-the-ground service
• +2 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and supporting.

• RENDRcoreTechnology or Integration · 13 May 2026Partnership with Australia Post's delivery orchestration platform to transform ANZ distribution businesses (Cryomed and LifeHealthcare) with greater logistics visibility, connectivity, efficiency, and customer experience through multi-carrier ecosystem providing real-time delivery partner selection.
• alphaXRTcoreStrategic or Co-development PartneralphaXRT joins EBOS MedTech portfolio in Australia and New Zealand, bringing deep specialist expertise in radiation oncology with EBOS MedTech's scale and reach. Represents partners including Accuray, RaySearch, Sun Nuclear/Mirion, TAE Lifesciences, MacroMedics.
• LifeHealthcare and Australian Biotechnologies PartnershipcoreStrategic or Co-development PartnerInternal partnership between LifeHealthcare's Plastic and Reconstructive Surgery division and Australian Biotechnologies to make Allovance ADM available to Australian and New Zealand patients, combining scientific excellence, local manufacturing, and surgical expertise.
• Nevada Donor NetworkcoreStrategic or Co-development PartnerPartnership with Nevada Donor Network for Origin Biologics to provide differentiated bone grafting solutions, honouring the gift of donation while delivering clinically grounded, cost-effective solutions.
• alphaXRT Global Technology PartnerscoreTechnology or IntegrationalphaXRT represents globally respected partners for radiation oncology: Accuray (treatment delivery), RaySearch (planning), Sun Nuclear/Mirion (medical physics and QA), TAE Lifesciences and MacroMedics (patient positioning).
• SAP, OptimizelysupportingTechnology or IntegrationTechnology partners including SAP and Optimizely accelerating AI capabilities through automation, predictive insights, and intelligent data layers to improve experiences, efficiency, and outcomes across EBOS MedTech ecosystem.
• Cambodia Outreach Program PartnerssupportingStrategic or Co-development PartnerNew Zealand orthopaedic spine surgeons, anaesthetists, nurses and LifeHealthcare representative initiative providing life-changing surgery for patients with severe spinal deformities in Cambodia.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Cardinal Health: US-listed healthcare distribution and products giant with global medical/surgical distribution operations including APAC. Comparable as a broad-incumbent distribution model that competes for similar hospital procurement and OEM distribution contracts that LifeHealthcare and Transmedic hold.
• Stryker: Global medical device manufacturer with strong orthopaedics, spine, surgical instruments and medical/surgical equipment portfolios, including direct APAC distribution. Comparable because Stryker both manufactures and distributes many of the same categories LifeHealthcare distributes, creating both partnership and competitive overlap.
• Medtronic: Global medical device leader with deep neurosurgery, spine, robotics and patient monitoring portfolios, plus established direct APAC distribution. Comparable as a broad incumbent whose own specialty surgery division competes with LifeHealthcare and Transmedic's manufacturer-partnered offerings.
• Johnson & Johnson MedTech: Global medical device arm of J&J spanning orthopaedics, spine, surgery and robotics with significant ANZ/SE Asia presence. Comparable as a broad incumbent whose DePuy Synthes and Ethicon divisions both partner with and compete against the distributors in EBOS MedTech's portfolio.

Direct peers

• MTF Biologics: US-based non-profit allograft tissue processor and distributor serving orthopaedic, spine, sports medicine and reconstructive surgery. Closest peer to Australian Biotechnologies and Origin Biologics in terms of donor-tissue-derived allograft manufacturing and clinical use cases.
• LifeNet Health: Non-profit allograft and regenerative medicine organisation producing bone, dermal, cardiovascular and sports medicine grafts from donated tissue. Comparable to EBOS MedTech's biologics subsidiaries in terms of proprietary tissue processing and surgeon-led education.
• Medigroup Australia: Australian-owned medical device and consumables distributor serving hospitals and healthcare professionals across multiple surgical and clinical specialties. Comparable in scale and customer base to LifeHealthcare, competing for similar hospital procurement contracts in ANZ.
• AlloSource: US allograft manufacturer producing acellular dermal matrices, bone grafts and sports medicine tissues from donated human tissue. Directly comparable to Origin Biologics and Allovance ADM in product category, regulatory pathway and regenerative surgery use cases.
• Elekta: Global manufacturer of radiation therapy and radiosurgery systems, with direct ANZ/SE Asia sales and service operations. Comparable because EBOS MedTech's alphaXRT distributes competing systems (e.g., Accuray) into the same oncology centres, making Elekta both a manufacturer-peer and an indirect competitor.
• Device Technologies Australia: Leading independent medical device distributor in Australia and New Zealand across surgical specialties including orthopaedics, spine, robotics and aesthetics. Direct competitor to LifeHealthcare in ANZ with overlapping specialty portfolios and a similar field-sales-led go-to-market.

Market position

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ebosmt

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EBOS MedTech